New 52 Week Low Today

Brainstorm Cell Therapeutics Inc BCLI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
3.57quote price arrow up+0.06 (+1.71%)
Volume
1,215
Close
3.51quote price arrow down-0.01 (-0.28%)
Volume
716,215
52 week range
3.10 - 17.95

...

Loading . . .

KEY STATS

  • Open3.56
  • Day High3.58
  • Day Low3.10
  • Prev Close3.52
  • 52 Week High17.95
  • 52 Week High Date10/09/20
  • 52 Week Low3.10
  • 52 Week Low Date03/05/21
  • Market Cap125.38M
  • Shares Out35.72M
  • 10 Day Average Volume1.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.14
  • 1 Year % Change-58.95

RATIOS/PROFITABILITY

  • EPS (TTM)-1.04
  • P/E (TTM)-3.39
  • Fwd P/E (NTM)-2.92
  • EBITDA (MRQ)-31.465M
  • ROE (MRQ)-273.75%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Brainstorm Cell Therapeutics Inc News

There is no recent news for this security.

Latest BCLI News From Our Partners

QUOTE FINDER

Profile

MORE
Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is engaged in developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD), among others. Its subsidiary, Brainstorm Cell Therapeutics Ltd. (the Israeli Subsidiary), holds rights to commercialize the technology, NurOwn. NurOwn is in clinical...
Jacob Frenkel
Chairman
Irit Arbel
Vice Chairman
Chaim Lebovits
Chief Executive Officer
Ralph Kern
President
David Setboun
Chief Operating Officer
Preetam Shah Ph.D.
Chief Financial Officer
Stacy Lindborg Ph.D.
Executive Vice President
Address
1325 Avenue of the Americas Fl 28
New York, NY
10019-6583
United States